Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

DKCRUSH-V: What Is Simple Is Not Always Best for the Left Main Coronary Artery

Courtesy of the SBHCI.

Angioplasty of true distal left main bifurcation lesions with a double-kissing (DK) crush two-stent strategy, compared with provisional stenting, results in lower rates of target lesion failure at 1 year.

DKCRUSH-V: lo más simple no siempre es lo mejor en el tronco de la coronaria izquierda

These findings were largely driven by lower rates of target vessel infarction and definite/probable stent thrombosis.


Read also: EXCEL-QOL Substudy: Similar Quality of Life both with CABG and Left Main PCI”.


This work, published simultaneously in the Journal of the American College of Cardiology and presented by lead investigator Dr. Shao-Liang Chen, is the first one to randomize patients with left main bifurcation lesions to the DK crush technique vs. provisional stenting.

 

The DK crush strategy had already resulted superior to the culotte stenting technique, but it had not been compared to provisional stenting, the preferred treatment for bifurcation lesions.

 

The DKCRUSH-V trial randomized 482 patients with left main bifurcation lesions (72.2% with unstable angina; mean Syntax score 30.6) to either provisional (n = 242) or DK crush stenting (n = 240) at 26 centers in China, Indonesia, Thailand, Italy, and the United States.


Read also: CULPRIT-SHOCK Results Will Transform Guidelines and Clinical Practice”.


At 1 year, the rate for the primary endpoint (a composite of cardiac death, target-vessel infarction, or clinically driven revascularization) was lower for patients in the DK-crush group than for those treated with provisional stenting (5.0% vs. 10.7%; hazard ratio [HR]: 0.42; 95% confidence interval [CI]: 0.21-0.85). The two-stent strategy also resulted in lower rates of target-vessel infarction (0.4% vs. 2.9%; p = 0.03) and definite/probable stent thrombosis (0.4% vs. 3.3%; p = 0.02).

 

In order to qualify for this study, operators needed to have performed at least 300 angioplasties, including procedures on left main coronary artery lesions, per year for at least 5 years.

 

These numbers are far from reality for most operators: for example, in the United States, 44% of all operators perform less than 50 angioplasties per year.

 

Courtesy of the Brazilian Society of Hemodynamics and Interventional Cardiology (SBHCI).

 

Original title: Double Kissing Crush Versus Provisional Stenting for Left Main Distal Bifurcation Lesions: DKCRUSH-V Randomized Trial.

Presenter: Chen S-L.

 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...